Precigen (PGEN) Revenue (2012 - 2026)

Precigen (PGEN) has 15 years of Revenue data on file, last reported at $23.3 million in Q1 2026.

• On a quarterly basis, Revenue rose 1633.93% year-over-year to $23.3 million in Q1 2026; TTM through Mar 2026 was $32.8 million, a 471.25% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, up 146.73% from the prior year.
• Revenue for Q1 2026 stood at $23.3 million, up from $7.9 million in the prior quarter.
• Over the last five years, Revenue for PGEN reached as high as $23.3 million in Q1 2026 and fell as low as -$14.5 million in Q4 2022.
• Historically, Revenue has averaged $3.2 million across 5 years, with a median of $1.3 million in 2023.
• Across the five-year window, Revenue sank 99.99% in 2023 and surged 94100.0% in 2025, its largest moves.
• Year by year, Revenue stood at -$14.5 million in 2022, then surged by 108.44% to $1.2 million in 2023, then soared by 200.49% to $3.7 million in 2024, then surged by 113.17% to $7.9 million in 2025, then surged by 195.6% to $23.3 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $23.3 million in Q1 2026, $7.9 million in Q4 2025, and $942000.0 in Q3 2025.